Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Open-market sale Director sold 7,324 shares at $16.16 ($118,349)
  2. 4 Open-market sale Director sold 45,539 shares at an average $16.45 ($749,002)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Director sold 19,565 shares at $15.14 ($296,269)
  8. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  10. 4 Gift Director gave 709 shares (gift)
  11. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 3,356 shares (option exercise)
  16. 4 Open-market sale President and CEO sold 70,000 shares at an average $15.15 ($1,060,701)
  17. 4 Open-market sale Chief Scientific Officer sold 30,000 shares at $16.28 ($488,298)
  18. 4 Open-market sale President and CEO sold 56,303 shares at $15.91 ($896,045)
  19. 4 Open-market sale Chief Financial Officer sold 12,823 shares at $15.55 ($199,335)
  20. 4 Open-market sale Chief Scientific Officer sold 27,165 shares at $15.71 ($426,803)

Page 8 of 21 · 414 filings